CHARLOTTE, N.C., October 23rd, 2026 — TUSK Practice Sales, a sell-side M&A advisory firm specializing in healthcare practice transitions, today released its Q4 2026 Plastic Surgery Market Report. The free report gives plastic surgery practice owners a clear, fact-based view of industry trends, private equity and management services organization (MSO) activity, and the planning steps that matter for owners considering a sale in the next 5 to 10 years.

Key findings from the report include:

Demand is strong and broadening. Surgeons performed 1.52 million cosmetic surgical procedures in 2025, up 7% from 2024, with the fastest growth in facial and restorative procedures and a 24% increase in patients aged 66 and older.
The surgeon workforce is tightening. Projected surgeon supply falls 17.2% between 2024 and 2037, from 10,310 to 8,540 full-time equivalents, while demand is projected to rise. In November 2020, 39.1% of surveyed plastic surgeons were aged 60 or older.
Private equity activity is selective and national. Activity exists throughout the United States and is concentrated in the Southeast and in large urban areas. Plastic surgery is a small specialty relative to other healthcare verticals, and consolidation remains relatively low.
Capital is ready to deploy. Private equity groups and MSOs hold committed capital heading into the first quarter of 2027, historically one of the most active quarters for healthcare M&A.
Preparation shapes outcomes. A well-prepared sale typically takes 6 to 9 months from start to close, and the report outlines the exit pathways available to single-surgeon, rural, and multi-provider practices.

The report explains how platforms are structured, what a recapitalization is and why it is a normal stage in a platform’s life, how state regulation shapes where MSOs operate, and how rollover equity works, using a worked example.

“Most plastic surgeons are exceptional clinicians who have never had to learn how private equity or an MSO works, and they shouldn’t have to figure it out alone,” said Kevin Cumbus, Founder and Partner at TUSK Practice Sales. “Demand for plastic surgery is growing while the supply of surgeons is projected to shrink, and that combination is drawing capital into the specialty. Owners who understand their options and start preparing early are the ones who get to choose how and when they transition.”

The Q4 2026 Plastic Surgery Market Report is available now at no cost at https://tuskpracticesales.com/q4-2026-plastic-surgery-market-report/

About TUSK Practice Sales

TUSK Practice Sales (“TUSK”) provides M&A Advisory services in the healthcare industry. TUSK has completed over $1.5B of transactions across all specialties. With an in-depth understanding of the marketplace and access to 100’s of buyers nationwide, we help our clients confidently pursue M&A transactions that maximize their long-term value. With our significant collective experience of over 125+ years of practice transactions, we offer our clients solutions that help them achieve their strategic and financial objectives. For more information, visit www.TuskPracticeSales.com